NeuBase acquires gene technology assets from Vera, shares up

NeuBase Therapeutics

28/01/2021 15:16

** Drug developer's shares  NBSE.O  rise 6.6% to $9.9 
    ** Co says it has agreed to acquire gene modulating
technology from privately held Vera Therapeutics
    ** Financial terms not disclosed by company  urn:newsml:reuters.com:*:nGNX7qpJTz
    ** Co says the deal extends the NeuBase's ability to correct
malfunctioning genes with precision to address the causes of
various diseases
    ** Deal expected to close in Q1 2021
    ** Stock has risen ~45% in the last 12 months 

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com;))